| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Outline of Final Research Achievements |
The curative therapy for ischemic organ failure is revascularization, whereas the phenomenon termed ischemia-reperfusion(I/R) injury has known to occur at the reperfusion period, and the control of I/R injury could affect patient prognosis. Ischemic or pharmacological preconditioning have known as the powerful means for regulating I/R injury, so we studied about modulating factors on myocardial preconditioning. We hypothesized that clinically used agents such as some anesthetics are modulating factors on myocardial preconditioning, and investigated using myocardial I/R injury rat model.
|
